Cheney KM - Search Results

1

A whole genome screen for HIV restriction factors.

Liu L, Oliveira NM, Cheney KM, Pade C, Dreja H, Bergin AM, Borgdorff V, Beach DH, Bishop CL, Dittmar MT, McKnight A. Liu L, et al. Among authors: cheney km. Retrovirology. 2011 Nov 14;8:94. doi: 10.1186/1742-4690-8-94. Retrovirology. 2011. PMID: 22082156 Free PMC article.

2

Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication.

Cheney KM, McKnight Á. Cheney KM, et al. PLoS One. 2010 Oct 20;5(10):e13521. doi: 10.1371/journal.pone.0013521. PLoS One. 2010. PMID: 20975956 Free PMC article.

3

In vivo emergence of HIV-1 highly sensitive to neutralizing antibodies.

Aasa-Chapman MM, Cheney KM, Hué S, Forsman A, O'Farrell S, Pellegrino P, Williams I, McKnight Á. Aasa-Chapman MM, et al. Among authors: cheney km. PLoS One. 2011;6(8):e23961. doi: 10.1371/journal.pone.0023961. Epub 2011 Aug 24. PLoS One. 2011. PMID: 21887353 Free PMC article.

4

HIV type 1 persistence in CD4- /CD8- double negative T cells from patients on antiretroviral therapy.

Cheney KM, Kumar R, Purins A, Mundy L, Ferguson W, Shaw D, Burrell CJ, Li P. Cheney KM, et al. AIDS Res Hum Retroviruses. 2006 Jan;22(1):66-75. doi: 10.1089/aid.2006.22.66. AIDS Res Hum Retroviruses. 2006. PMID: 16438648

5

Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.

Carr JM, Cheney KM, Coolen C, Davis A, Shaw D, Ferguson W, Chang G, Higgins G, Burrell C, Li P. Carr JM, et al. Among authors: cheney km. J Clin Microbiol. 2007 Apr;45(4):1288-97. doi: 10.1128/JCM.01926-06. Epub 2007 Feb 21. J Clin Microbiol. 2007. PMID: 17314225 Free PMC article.

6

Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products.

Carr JM, Davis AJ, Coolen C, Cheney K, Burrell CJ, Li P. Carr JM, et al. Virology. 2006 Jul 20;351(1):80-91. doi: 10.1016/j.virol.2006.03.027. Epub 2006 May 2. Virology. 2006. PMID: 16631224 Free article.

7

CBFA2T3-ZNF651, like CBFA2T3-ZNF652, functions as a transcriptional corepressor complex.

Kumar R, Cheney KM, Neilsen PM, Schulz RB, Callen DF. Kumar R, et al. Among authors: cheney km. FEBS Lett. 2010 Mar 5;584(5):859-64. doi: 10.1016/j.febslet.2010.01.047. Epub 2010 Jan 30. FEBS Lett. 2010. PMID: 20116376 Free article.

8

ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.

Kumar R, Manning J, Spendlove HE, Kremmidiotis G, McKirdy R, Lee J, Millband DN, Cheney KM, Stampfer MR, Dwivedi PP, Morris HA, Callen DF. Kumar R, et al. Among authors: cheney km. Mol Cancer Res. 2006 Sep;4(9):655-65. doi: 10.1158/1541-7786.MCR-05-0249. Mol Cancer Res. 2006. PMID: 16966434 Free article.

9

CBFA2T3-ZNF652 corepressor complex regulates transcription of the E-box gene HEB.

Kumar R, Cheney KM, McKirdy R, Neilsen PM, Schulz RB, Lee J, Cohen J, Booker GW, Callen DF. Kumar R, et al. Among authors: cheney km. J Biol Chem. 2008 Jul 4;283(27):19026-38. doi: 10.1074/jbc.M709136200. Epub 2008 May 2. J Biol Chem. 2008. PMID: 18456661 Free article.

10

Identification of ANKRD11 as a p53 coactivator.

Neilsen PM, Cheney KM, Li CW, Chen JD, Cawrse JE, Schulz RB, Powell JA, Kumar R, Callen DF. Neilsen PM, et al. Among authors: cheney km. J Cell Sci. 2008 Nov 1;121(Pt 21):3541-52. doi: 10.1242/jcs.026351. Epub 2008 Oct 7. J Cell Sci. 2008. PMID: 18840648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page